Rockwell Medical (RMTI) Shares Outstanding (Weighted Average) (2010 - 2026)

Rockwell Medical has reported Shares Outstanding (Weighted Average) for 17 years, with the latest figure at $39.4 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 15.57% year-over-year to $39.4 million; the trailing twelve-month figure through Mar 2026 stood at $39.4 million (up 15.57% YoY), and the FY2025 full-year result was $36.0 million, up 15.83% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $39.4 million, up from $36.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $39.4 million in Q1 2026, with the low at $8.5 million in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $25.9 million across 5 years, with a median of $29.3 million in 2024.
• The largest YoY upside for Shares Outstanding (Weighted Average) was 116.69% in 2022 against a maximum downside of 0.42% in 2022.
• Rockwell Medical's Shares Outstanding (Weighted Average) stood at $14.3 million in 2022, then jumped by 63.05% to $23.3 million in 2023, then jumped by 33.17% to $31.1 million in 2024, then gained by 15.83% to $36.0 million in 2025, then rose by 9.57% to $39.4 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $39.4 million (Q1 2026), $36.0 million (Q4 2025), and $34.8 million (Q3 2025), per Business Quant data.